Changes in Recommendations for Diagnosis, Disease Severity, and Treatment of C difficile Infection in the 2017 Update to the IDSA/SHEA Clinical Practice Guidelines
The updated guidelines recommend targeting those with active infection and avoiding treatment of “carriers” of C difficile who are colonized but not symptomatic.
Managing Reluctant Antibiotic Stewards: Advice From an ID Physician and an ID Pharmacist
Although challenging, it is not impossible to change some outlier behaviors.
Teamwork Makes the Dream Work
The rise of ID pharmacy as a profession has been complementary to services uniquely offered by ID physicians, not in competition with them.
Cutting the Drug Development Red Tape
MJH Associates, Inc & the FDA are both committed to eliminating inefficiencies and hype to deliver the most timely and relevant information to health care providers.
Study Shows Sulfonamide Antibacterials Capable of Reversing Azole Resistance in Candida albicans
Preliminary studies provide convincing evidence for the synergistic use of sulfonamide agents with azole antifungals.
It Takes Two to TANGO With a Carbapenemase
Because of the global rise in antimicrobial resistance, meropenem-vaborbactam, the first carbapenem/β-lactamase combina­tion medication, is a welcome new antibac­terial.
Flu Season 2017-2018: A Look at What Happened and What's to Come
Experts continue to recommend that people get the seasonal flu vaccine as the scientific community works toward a universal vaccine offering lifelong protection against multiple strains.
Searching for the Cause of Hearing Loss in a Patient With HIV
Early diagnosis and treatment were essential to ensuring a good prognosis.
Is Investment in New Technologies for Diagnosing Schistosomiasis Justified in an Era of Schistosoma Elimination?
The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.
Diagnosis and Management of Gram-Negative Nosocomial Infections
Patient and institutional history, as well as the individual niches of the new antibiotics, need to be considered when selecting a treatment for gram-negative infections.
Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract Infections
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis
Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.
Another Adverse Effect of the Opioid Epidemic: Hepatitis C Infections
An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3.
2 Commerce Drive Cranbury, NJ 08512